Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma

Søren Pedersen , Renate Engelstätter , Hans-Jochen Weber , Sabine Hirsch , László Barkai , Andrej Emeryk , Heinrich Weber , Jan Vermeulen

Ciclesonide is a new inhaled corticosteroid (ICS). Information about its clinical efficacy and safety in relation to other ICS in children is needed for clinical positioning.

Mots clés: Asthma; children; ciclesonide; efficacy; fluticasone propionate; hypothalamic–pituitary–adrenal axis; inhaled corticosteroids; safety

Søren Pedersen, Renate Engelstätter, Hans-Jochen Weber, Sabine Hirsch, László Barkai, et al.. Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma. Pulmonary Pharmacology & Therapeutics, 2009, 22 (3), pp.214. ⟨10.1016/j.pupt.2008.12.013⟩. ⟨hal-00530441⟩